SBI Securities’s VanEck Biotech ETF BBH Stock Holding History

SBI Securities’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62K	Buy	305 +17	+6%	+$3.2K	﹤0.01%	1083
2026 Q1	$54.2K	Hold	288	–	–	﹤0.01%	1067
2025 Q4	$54.5K	Sell	288 -30	-9%	-$5.55K	﹤0.01%	1047
2025 Q3	$52.7K	Sell	318 -114	-26%	-$18.6K	﹤0.01%	1070
2025 Q2	$66.2K	Buy	432 +1	+0.2%	+$149	﹤0.01%	951
2025 Q1	$67.8K	Sell	431 -85	-16%	-$13.8K	﹤0.01%	871
2024 Q4	$81K	Buy	+516	New	+$86.8K	﹤0.01%	824

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities's BBH Position: Q2 2026 in Review

SBI Securities increased its VanEck Biotech ETF (BBH) stake by 5.9% in Q2 2026, buying an estimated $3.2K and bringing the position to 305 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

SBI Securities first reported a position in BBH in Q4 2024 and has held it in 7 quarters since. The position peaked at $81K in Q4 2024. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

SBI Securities held 305 shares of VanEck Biotech ETF worth $62K as of Q2 2026.
SBI Securities bought 17 VanEck Biotech ETF shares in Q2 2026, an estimated $3.2K.
VanEck Biotech ETF made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1083 holding.
SBI Securities first reported a position in VanEck Biotech ETF in Q4 2024 and has held it in 7 quarters since.
SBI Securities's VanEck Biotech ETF position peaked at $81K in Q4 2024.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.